发明名称 HEXAPEPTIDE
摘要 A hexapeptide represented by formula (II): A-B-Pro-C-D-E ... (I) where A represents an L- or D- form of arginine or lysine whose N-terminal amino group is alkylated or acylated, B represents an L- or D- form of argine, lysine, or histidine, Pro represents an L- or D- form of proline, C represents an L- or D- form of tyrosine, tryptophan, or phenylalanine, D represents an L- or Dform of valine, isolencine, or leucine, and E represents an L-or D- form of valine, isolencine, or lencine, one of the hydrogen atoms of the amino group of which may be substituted a C1 to C4 alkyl group, and C-terminal carboxyl group of which is substituted with -COOR*, -CH2OR, or -CONHR wherein R* represents a C1 to C4 alkyl group, and R represents a hydrogen atom or an C1 to C4 alkyl group. The hexapeptide or a pharmaceutically acceptable salt of the hexapeptide is useful as medical agent such as an anti-edematous agent, an anti-shock agent, an anti-thrombus agent, an anti-arteriosclerotic agent, an anti-allergic agent, a hypotensive agent, a would healing agent, and an anti-inflammatory agent.
申请公布号 CA2074967(A1) 申请公布日期 1993.01.31
申请号 CA19922074967 申请日期 1992.07.30
申请人 TSUMURA & CO. 发明人 AMAGAYA, SAKAE;FUJIWARA, TADAMI;ABURADA, MASAKI;NAGASAWA, MICHIO;OYAMA, TSUTOMU
分类号 A61K38/00;A61P3/00;A61P7/02;A61P9/10;A61P9/12;A61P29/00;A61P37/08;A61P43/00;C07K5/10;C07K7/06;(IPC1-7):C07K7/06;A61K38/08 主分类号 A61K38/00
代理机构 代理人
主权项
地址